Past as Prologue—Use of Rubella Vaccination Program Lessons to Inform COVID-19 Vaccination

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Dixon, Meredith G. ; Reef, Susan E. ; Zimmerman, Laura A. ; Grant, Gavin B.
• Description:
  The rapid rollout of vaccines against COVID-19 as a key mitigation strategy to end the global pandemic might be informed by lessons learned from rubella vaccine implementation in response to the global rubella epidemic of 1963-1965. That rubella epidemic led to the development of a rubella vaccine that has been introduced in all but 21 countries worldwide and has led to elimination of rubella in 93 countries. Although widespread introduction and use of rubella vaccines was slower than that for COVID-19 vaccines, the process can provide valuable insights for the continued battle against COVID-19. Experiences from the rubella disease control program highlight the critical and evolving elements of a vaccination program, including clearly delineated goals and strategies, regular data-driven revisions to the program based on disease and vaccine safety surveillance, and evaluations to identify the vaccine most capable of achieving disease control targets.
• Subjects:
  COVID-19 Vaccines COVID-19/prevention & Control Epidemiology Humans Immunization Programs Rubella Rubella Vaccine Vaccination
• Source:
  Emerg Infect Dis. 2022; 28(Suppl 1):S225-S231
• Pubmed ID:
  36502405
• Pubmed Central ID:
  PMC9745252
• Document Type:
  Journal Article
• Volume:
  28
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:2594bcabb6b059b4f04e649550e37f89ff5ed682a590ae0cf8b1f834a768a1a3
• Download URL:
  https://stacks.cdc.gov/view/cdc/123307/cdc_123307_DS1.pdf
• File Type:
  [PDF - 725.85 KB ]